Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate Potassium)
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a beta-lactam penicillin) and clavulanate potassium (a beta-lactamase inhibitor). The inhibitor expands the spectrum of activity to include beta-lactamase-producing bacteria that are resistant to amoxicillin alone.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections
* Lower respiratory tract infections
## Adult Dosing
* **Standard dosing:** 875 mg amoxicillin / 125 mg clavulanate every 12 hours.
* **Severe infections:** 875 mg / 125 mg every 8 hours depending on local institutional guidelines/severity of infection.
* **Max daily dose:** Total amoxicillin dose should not exceed 4–6 grams per day depending on the formulation.
## Pediatric Dosing
Dosing is based on the amoxicillin component. Standard suspension (usually 4:1 or 7:1 ratios):
* **Mild to moderate infection:** 20–45 mg/kg/day (based on amoxicillin) divided every 12 hours.
* **Severe infection/Otitis media:** 80–90 mg/kg/day divided every 12 hours.
* **Note:** Always verify the specific suspension concentration (e.g., 200mg/5mL, 400mg/5mL) before calculating mL volume.
## Dose Adjustments
* **Renal Impairment (CrCl <30 mL/min):** Avoid the 875 mg tablet. Dosage adjustments are required based on creatinine clearance. Use extended-release formulations are generally contraindicated in renal impairment.
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of serious hypersensitivity (anaphylaxis) to any penicillin or cephalosporins.
* History of cholestatic jaundice or hepatic dysfunction associated with previous amoxicillin/clavulanate therapy.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (very common), nausea, vomiting, abdominal pain.
* **Hepatic:** Elevated AST/ALT, cholestatic jaundice (more common in males and patients >65).
* **Dermatologic:** Rash (monitor for IgE-mediated reactions vs. delayed non-allergic maculopapular rash).
* **Other:** Candidiasis (oral or vaginal).
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease renal clearance, increasing risk of toxicity.
* **Warfarin:** May increase INR and risk of bleeding by altering gut flora (vitamin K synthesis).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum concentrations.
* **Oral Contraceptives:** Potential for reduced efficacy (though evidence is debated, backup contraception is often advised).
## Monitoring
* **Renal Function:** Monitor baseline creatinine and BUN.
* **Hepatic Function:** Liver function tests (LFTs) in patients with prolonged therapy.
* **Hypersensitivity:** Monitor for signs of anaphylaxis or severe cutaneous adverse reactions (SCARs) during the first dose and throughout therapy.
## Clinical Pearls
* **Take with food:** Administer at the start of a meal to minimize gastrointestinal upset and increase absorption.
* **Suspension Handling:** Must be refrigerated and discarded after 10 days.
* **Clavulanate dose cap:** The amount of clavulanate is fixed in many tablets. Do not double up 875 mg tablets to reach higher doses, as this will lead to excessive clavulanate intake and increased diarrhea.
* **Local Protocol:** Always adhere to local antibiograms regarding susceptibility patterns for *S. pneumoniae* and *H. influenzae*.
***
*Disclaimer: This information is for educational purposes only. Clinical guidelines and prescribing information vary by region and institutional policy. Always verify specific dosing, safety precautions, and patient-specific contraindications via up-to-date drug formularies and local clinical protocols before prescribing or administering medication.*
